Anthony Mac, OD
Corneal and Contact Management · San Antonio, TXNPI 1982379301
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,259 of the $5,296 with a category attached, or 80.4%. 14 manufacturers reported payments, led by Alcon at 29.2% of the total. Reporting peaked in 2023 at $2,794 and has fallen 73.0% since, to $755 in 2025.
Across 66 payments — averaging $80.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Bausch & Lomb Americas Inc.$1K
- Dompe US, Inc.$448
- AbbVie$435
- Oyster Point Pharma, Inc.$240
- Biotissue Holdings Inc.$232
- plus $937 from 8 others
What the payments were for
- Travel & lodging$1,01919%
- Food & beverage$4,25980%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 10 | $1,547 |
| Bausch & Lomb Americas Inc. | 29 | $1,457 |
| Dompe US, Inc. | 4 | $448 |
| AbbVie(2 entities) | 4 | $435 |
| Oyster Point Pharma, Inc. | 3 | $240 |
| Biotissue Holdings Inc. | 2 | $232 |
| Glaukos Corporation | 2 | $225 |
| Tarsus Pharmaceuticals, Inc. | 3 | $163 |
| Harrow Eye, LLC | 2 | $152 |
| Novartis | 3 | $136 |
| Amgen | 1 | $125 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $92 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Coopervision Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIR OPTIX$1,356
- Dailies Aqua Comfort Plus$1,356
- DAILIES TOTAL1 Multifocal$831
- XIIDRA$375
- MIEBO$375
- Oxervate$357
- INFUSE$355
- TYRVAYA$222
- DURYSTA$218
- Prokera$160
- AmnioGraft$160
- Photrexa Viscous and Photrexa$150
- TRYPTYR$125
- VYZULTA$125
- TEPEZZA$125
- VEVYE$125
- OZURDEX$117
- XDEMVY$110
- VUITY$101
How this compares
$5,296 in reported general payments places this provider in the 80th percentile of 103 corneal and contact management providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other corneal and contact management in San Antonio
- Roberto SaenzSan Antonio$171K
- Jack AbramsonSan Antonio$5K
- Louis PetersSan Antonio$4K
- Kristen KautzmanSan Antonio$3K
- Maurice WilsonConroe$362K
- Fariba ParmerGrapevine$26K
- Vissett SunHouston$13K
- Napoleon LoveroHouston$12K
- Sairah MalikHouston$10K
- Darlene JonesPlano$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.